Following the withdrawal of funding from the National Institute for Health and Care Research at the end of March 2023, the Cochrane Cystic Fibrosis and Genetic Disorders Group has focussed its activities on just cystic fibrosis in order to meet the contractual requirements of the new funding agreement. Information related to previous activities and members is presented in these pages.